A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy

NCT05568459 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia B

Interventions

OTHER: Non-Interventional

Sponsor

Regeneron Pharmaceuticals